Vandria (private company)
See something wrong or missing? Let us know
Offices:Lausanne
Business model:B2B
Vandria is a Swiss biotech startup developing therapeutics to rejuvenate cells to treat age-related and chronic illnesses
Investors:
we tracked 3 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 30.68M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Vandria
| Name | Criteria | |
|---|---|---|
![]() |
Ability Pharma
67%
|
|
![]() |
AbolerIS Pharma
67%
|
|
![]() |
Acesion Pharma
67%
|
|
![]() |
Beckley Psytech
67%
|
|
![]() |
CatalYm
67%
|
|
![]() |
Cinclus Pharma
67%
|
|
![]() |
InnovaFeed SAS
67%
|
|
![]() |
Memo Therapeutics
67%
|
|
![]() |
NMD Pharma
67%
|
|
![]() |
Peptone
67%
|
|







Belgium
Netherlands
Austria
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal